The Economist's health editor Natasha Loder wrote that advances in mRNA technology have spawned groundbreaking new cancer vaccine trials around the world, from melanoma to colorectal cancers.
To find out more about how cancer vaccines work, vaccinologist Helen Petousis-Harris, associate professor at the University of Auckland, joins Maggie Tweedie.